drugset / Trial / NCT02168270

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

NCT02168270

NaSingle-groupOpen-labelTreatment

Summary

This phase I trial studies the side effects and best dose of ascorbic acid when given together with temozolomide in treating patients with high-grade glioma that has come back. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Ascorbic acid contains ingredients that may prevent or slow the growth of high-grade gliomas. Giving temozolomide with ascorbic acid may kill more tumor cells.

Timeline

Start
2014-06-16
Primary completion
2015-08-20
Completion
2015-08-20

Drugs

EvaluationDrugModalityDoseRoute
Background Temozolomide Small molecule Oral